Stryker’s Spine division, Allendale, N.J., introduces the Tritanium Posterior Lumbar (PL) Cage, a 3D-printed intervertebral body fusion device made of Tritanium, a highly porous titanium alloy designed for bone in-growth and biological fixation. Stryker’s 3D-printing process allows for the creation of porous structures that are designed to mimic cancellous bone, a type of spongy bone tissue. The PL cage aids in lumbar spinal fixation for patients with degenerative disc disease.
“We are pleased to bring this technology advancement to spine surgeons and their patients,” said Stryker’s Spine division President Brad Paddock. “Stryker is a pioneer in 3D additive manufacturing, investing nearly 15 years in research and development. Unlike traditional manufacturing techniques, the flexibility of our 3D additive manufacturing capabilities allows us to precisely engineer and produce porous Tritanium devices. The Tritanium PL Cage is an exciting addition to our growing suite of unique spinal products.”
“Spine surgeons need a cage that has the capability of bony integration or bony in-growth, as well as radiolucency so that we can evaluate the fusion long term,” said Dr. Wellington Hsu, M.D., Orthopaedic Surgeon at Northwestern Medical Group. “Because Tritanium has favorable radiographic capabilities, as well as the integrative surface technology, that really in my opinion is what I would ask for from an interbody cage.”
Implanted by a posterior approach, the Tritanium PL Cage is available in a variety of widths, lengths, heights, and lordotic angles that can adapt to a variety of patient anatomies. Its large lateral windows and open architecture allow visualization of fusion on CT and X-ray, and its solid-tipped, precisely angled serrations are designed to allow for bidirectional fixation and to maximize surface area for endplate contact with the cage. The Tritanium PL Cage also is designed to minimize subsidence into the endplates.
The Tritanium PL Cage is produced at Stryker’s state-of-the-art 3D additive manufacturing facility, and will be widely available to orthopaedic and neurosurgeons in mid-2016.
